Uwell Biopharma, Inc. (TPEX:7902)
Taiwan
· Delayed Price · Currency is TWD 46.75
-0.20 (-0.43%)
At close: Apr 28, 2026
Uwell Biopharma Market Cap
Uwell Biopharma has a market cap or net worth of 9.35 billion as of April 28, 2026.
Market Cap
9.35B
Enterprise Value
9.13B
Revenue
450.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
46.75
Market Cap Chart
Since January 22, 2026, Uwell Biopharma's market cap has increased from 5.52B to 9.35B, an increase of 69.38%. That is a compound annual growth rate of 641.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 9.35B | 69.38% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADDCN Technology | 9.35B |
| Enli Technology Co.,Ltd | 9.32B |
| Liton Technology | 9.43B |
| BaaS Innovation | 9.44B |
| Gongwin Biopharm Holdings | 9.48B |
| Feedback Technology | 9.19B |
| Microbio | 9.18B |
| Cashbox Partyworld | 9.54B |